Table 2 AKI incidence and 3-year outcomes of patients with different degree of hidden renal dysfunction
eGFR ≥ 90 (no renal dysfunction) | 60 ≤ eGFR < 90 (hidden renal dysfunction) | eGFR < 60 (known renal dysfunction) | ||
|---|---|---|---|---|
All (n = 1744) | N | 829 (47.53%) | 857 (49.14%) | 58 (3.33%) |
AKI incidence | 271 (32.69%) | 301 (35.12%) | 26 (44.83%) | |
In-hospital mortality | 19 (2.29%) | 40 (4.67%) a | 3 (5.17%) | |
3-year mortality | 61 (7.36%) | 103 (12.02%) ab | 18 (31.03%) | |
Progressive CKD incidence | 22 (2.65%) | 52 (6.07%) ab | 9 (15.52%) | |
< 65 years (n = 1356) | N | 728 (53.69%) | 597 (44.03%) | 31 (2.29%) |
AKI incidence | 223 (30.63%) | 187 (31.32%) | 13 (41.94%) | |
In-hospital mortality | 15 (2.06%) | 28 (4.69%) a | 1 (3.23%) | |
3-year mortality | 36 (4.95%) | 37 (6.20%)b | 5 (16.13%) | |
Progressive CKD incidence | 18 (2.47%) | 32 (5.36%) a | 4 (12.90%) | |
≥ 65 years (n = 388) | N | 101 (26.03%) | 260 (67.01%) | 27 (6.96%) |
AKI incidence | 48 (47.52%) | 114 (43.85%) | 13 (48.15%) | |
In-hospital mortality | 4 (3.96%) | 12 (4.62%) | 2 (7.41%) | |
3-year mortality | 25 (24.75%) | 66 (25.38%)b | 13 (48.15%) | |
Progressive CKD incidence | 4 (3.96%) | 20 (7.69%) | 5 (18.52%) | |